Life sciences, healthcare, and pharmaceutical research are pressing issues in the US and abroad. As the dispute involving federal healthcare strategies continues in Washington D.C., a peaceful movement is just starting to take a form that seeks to change the marketplace without dealing with any political opinion.
That trend is being led by an increasing number of companies in the healthcare industry that are currently working to shake the status quo by transforming data into valuable information that can help with every aspect of healthcare.
Over 80% of healthcare data is not organized. Disorganized data is basically information that doesn’t actually have any specified design or is not assembled in a specific way. Therefore, companies and software that can translate this data and assist to make this information helpful for healthcare companies are extremely needed.
Although this disorganized data is a big majority of the information at hand, just 23% of existing healthcare data insights actually originates from it. That indicates it is a grossly underutilized bulk of information just waiting to be structured and organized.
Existing techniques and methods available to do this kind of job need extensive human intervention, therefore they’re time-consuming and very susceptible to unintentional errors. This is a pressing concern for pharmaceutical companies, but recently we’ve seen how the packaging world has begun to tackle this issue – any pharmaceutical packaging company can bare as a witness to this. Fortunately, there is a group of tech innovators already working to fix these issues for life sciences.
Smart searches: Based on consumer’s ideas
For example, a lot of pharma companies have had a very hard time when it comes to searching and storing available data. And because of this issues, scientists are kept in the dark regarding studies and research relevant to their line of work. As a result of this, many will keep on heading the wrong direction. If this search approach is not updated, scientists and researchers will only have a very little piece of the whole data – and it gets obsolete within days.
Businesses like Innoplexus are an excellent example of real progress regarding this issue. They established new analytics and search tools specially made for the medical market that is actually making medical data very easy to access and use. In fact, what’s more interesting and exciting about this service is the types of inquiries that can be made. By increasing the precision of these inquiries, data companies can minimize the quantity of time invested looking for critical information.
Boosting drug production
The FDA already started in 2015 to dig into cloud computing in order to help accelerate the drug approval process. A drug can take as much as 12 years to be developed, beginning with its creation until the final FDA approval. The FDA’s outdated paper procedures take a good part of the guilt, but cloud services might actually help to improve the process and achieve faster approval times.
Besides that, the production process is another aspect of the industry that might receive a big boost from data analytics. Drug designers with better search tools can find better study participants and identify issues with a drug earlier in the process.
Lowering costs can also allow reinvestment into other key functions like new treatments or medications. One of the many ways this can be achieved is by creating databases that avoid redundancies in healthcare companies. A large number of businesses with big structures can definitely benefit from this, as they are the most prone to suffer from these redundancies.
In the last 5 years, life science companies have begun to include technology in their daily work. Examples consist of pharmaceutical and academic organizations buying licenses and teaming up with tech businesses. We can anticipate that digital therapeutics will end up being mainstream, while devoted app shops for Life Sciences data will change the way data is accessed and consumed.
As data analytics start to offer more options in healthcare, we can anticipate healthcare and pharmaceutical businesses to invest more in their data, and more start-ups will emerge to assist them to understand all of it. The hopeful outcome will be much better health options for everybody.